Biological behaviour of primary osteosarcoma of the digits, metacarpal and metatarsal bones in dogs.
Journal
Veterinary and comparative oncology
ISSN: 1476-5829
Titre abrégé: Vet Comp Oncol
Pays: England
ID NLM: 101185242
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
21
08
2020
received:
12
06
2020
accepted:
02
09
2020
pubmed:
8
9
2020
medline:
27
1
2022
entrez:
7
9
2020
Statut:
ppublish
Résumé
Osteosarcoma (OSA) arising from the digits, metatarsal and metacarpal bones is rare and may carry a better prognosis compared with other locations. The aim of this study was to retrospectively evaluate the biological behaviour, the progression free interval (PFI), the survival time (ST) and evaluate the effect of adjuvant chemotherapy for OSA affecting these bones. Medical records from two academic institutions were reviewed and 15 cases were included. Descriptive statistics were used for signalment and history. For estimation of median PFI and median ST, the Kaplan-Meier method was utilized. The prognostic effect of chemotherapy, lymphocyte and monocyte count was investigated. Log-rank analysis was used to compare PFI and ST between groups. The overall median PFI and median ST were 377 and 687 days, respectively. No significant differences were noted for any of the variables evaluated. In this study, dogs affected by OSA of digits, metacarpal and metatarsal bones appear to have a longer ST compared with dogs with OSA of other appendicular locations. A study with a larger number of patients is needed to confirm these results and investigate the potential benefit of adjuvant chemotherapy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
735-742Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Brodey RS, Mc GJ, Reynolds H. A clinical and radiological study of canine bone neoplasms. J Am Vet Med Assoc. 1959;134:53-71.
Brodey RS, Sauer RM, Medway W. Canine bone neoplasms. J Am Vet Med Assoc. 1963;143:471-495.
Brodey RS, Riser WH. Canine osteosarcoma. A clinicopathologic study of 194 cases. Clin Orthop Relat Res. 1969;62:54-64.
Dorfman SK, Hurvitz AI, Patnaik AK. Primary and secondary bone tumours in the dog. J Small Anim Pract. 1977;18:313-326.
Ling GV, Morgan JP, Pool RR. Primary bone rumors in the dog: a combined clinical, radiographic, and histologic approach to early diagnosis. J Am Vet Med Assoc. 1974;165:55-67.
Tuohy JL, Shaevitz MH, Garrett LD, Ruple A, Selmic LE. Demographic characteristics, site and phylogenetic distribution of dogs with appendicular osteosarcoma: 744 dogs (2000-2015). PLoS One. 2019;14:e0223243.
Heyman SJ, Diefenderfer DL, Goldschmidt MH, Newton CD. Canine axial skeletal osteosarcoma. A retrospective study of 116 cases (1986 to 1989). Vet Surg. 1992;21:304-310.
Ehrhart NP, Christensen NI, Fan TM. Tumors of the skeletal system. In: Vail DM, Thamm DH, Liptak J, Page RL, eds. Small Animal Clinical Oncology. 6th ed. St Louis: Elsevier Saunders; 2020:524-564.
Kruse MA, Holmes ES, Balko JA, Fernandez S, Brown DC, Goldschmidt M. Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones. Vet Pathol. 2013;50:704-708.
Sottnik JL, Rao S, Lafferty M, et al. Association of blood monocyte and lymphocyte count and disease-free interval in dogs with osteosarcoma. J Vet Intern Med. 2010;24:1439-1444.
Saam DE, Liptak JM, Stalker MJ, Chun R. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006). J Am Vet Med Assoc. 2011;238:195-206.
Boston SE, Ehrhart NP, Dernell WS, Lafferty M, Withrow SJ. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004). J Am Vet Med Assoc. 2006;228:1905-1908.
Hillers KR, Dernell WS, Lafferty MH, Lafferty M, Withrow SJ, Lana SE. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc. 2005;226:1364-1367.
Coyle VJ, Rassnick KM, Borst LB, et al. Biological behaviour of canine mandibular osteosarcoma. A retrospective study of 50 cases (1999-2007). Vet Comp Oncol. 2015;13:89-97.
Selmic LE, Lafferty MH, Kamstock DA, et al. Outcome and prognostic factors for osteosarcoma of the maxilla, mandible, or calvarium in dogs: 183 cases (1986-2012). J Am Vet Med Assoc. 2014;245:930-938.
Gamblin RM, Straw RC, Powers BE, Park RD, Bunge MM, Withrow SJ. Primary osteosarcoma distal to the antebrachiocarpal and tarsocrural joints in nine dogs (1980-1992). J Am Anim Hosp Assoc. 1995;31:86-91.
Marino DJ, Matthiesen DT, Stefanacci JD, Moroff SD. Evaluation of dogs with digit masses: 117 cases (1981-1991). J Am Vet Med Assoc. 1995;207:726-728.
Anninga JK, Picci P, Fiocco M, et al. Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup. Virchows Arch. 2013;462:109-120.
Sneppen O, Dissing I, Heerfordt J, Schiödt T. Osteosarcoma of the metatarsal bones: review of the literature and report of a case. Acta Orthop Scand. 1978;49:220-223.
Okada K, Wold LE, Beabout JW, Schives TC. Osteosarcoma of the hand a clinicopathologic study of 12 cases. Cancer. 1993;72:719-725.
Endo-Munoz L, Bennett TC, Topkas E, et al. Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma. Vet Comp Oncol. 2020;18:206-213.
Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014;28:554-563.
Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc. 1992;200:531-533.
Shapiro W, Fossum TW, Kitchell BE, Couto CG, Theilen GH. Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc. 1988;192:507-511.
Kraegel SA, Madewell BR, Simonson E, Gregory CR. Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989). J Am Vet Med Assoc. 1991;199:1057-1059.
Khanna C, Prehn J, Hayden D, et al. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy. Clin Cancer Res. 2002;8:2406-2412.
Mason NJ, Gnanandarajah JS, Engiles JB, et al. Immunotherapy with a HER2-targeting listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma. Clin Cancer Res. 2016;22:4380-4390.
Phillips B, Powers BE, Dernell WS, et al. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc. 2009;45:33-38.
Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). J Vet Intern Med. 1996;10:76-81.
Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med. 1991;5:205-210.
Vail DM, Kurzman ID, Glawe PC, et al. STEALTH liposome- encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial. Cancer Chemother Pharmacol. 2002;50:131-136.
Sadiq M, Ismail M, Dhanya K, Meganath P. Parosteal osteosarcoma of the proximal phalanx of a finger. J Hand Surg. 2019;45:663. https://doi.org/10.1016/j.jhsa.2019.08.006.
Phillips A, Kulendra E, Bishop E, Monk M, Parsons K, House A. Clinical outcome and complications of thoracic and pelvic limb stump and socket prostheses. Vet Comp Orthop Traumatol. 2017;30:265-271.
Wendland TM, Seguin B, Duerr FM. Retrospective multi-center analysis of canine socket prostheses for partial limbs. Front Vet Sci. 2019;6:100.
Carr BJ, Canapp S, Petrovitch JL, Campana D, Canapp D, Leasure CS. Retrospective study on external canine limb prosthesis used in 24 patients. Vet Evidence. 2018;3:1-12. https://doi.org/10.18849/ve.v3i1.118.